Solid tumours ... malignant tumours posing significant health risks due to their aggressive nature and potential to spread. Recent research has focused on understanding the epidemiology ...

Tumor-Node-Metastasis (TNM) Staging System: A classification system used to describe the extent of cancer spread, based on the size of the tumor (T), the involvement of lymph nodes (N), and the ...

Staging can help determine the spread of the disease and inform treatment. Stage 0/In situ: Known as precancer. Typically no symptoms. Stage 1: Tumor is invasive but has ... Squamous Cell Carcinoma of ...

"What is a tumor?" This is the fundamental question to answer if we want to treat cancer effectively. Our vision of cancer ...

A team led by the Cancer Immunogenomics group at the Josep Carreras Leukaemia Research Institute, the Computational Biology group at the Barcelona Supercomputing Center and the Germans Trias i Pujol ...

A team led by the Cancer Immunogenomics group at the Josep Carreras Leukaemia Research Institute, the Computational Biology group at the Barcelona Supercomputing Center and the Germans Trias i Pujol ...

A multicenter collaboration has identified a potential new treatment for an aggressive sarcoma arising in the nerves. The ...

An enhanced model that integrates non-AJCC clinical features provides clinicians with a more accurate tool for identifying high-risk patients with MCC.

The clinical approach, epidemiology, diagnostic procedures, and management, along with followup of superficial spreading malignant melanoma ... depending on tumor invasiveness and metastasis.

Glioblastoma: New Treatment Attacks Brain Tumors from Multiple Angles Nov. 12, 2024 — Glioblastoma is the most common kind of malignant brain tumor in adults. So far, no treatment has been able ...

The International Federation of Gynecology and Obstetrics (FIGO) staging systems for vulva ... IA Tumor confined to the vulva or perineum, ≤ 2cm in size with stromal invasion ...

Phase Ib study of gevokizumab (GEVO) in combination with standard-of-care (SoC) anticancer therapies in patients (pts) with metastatic colorectal cancer (mCRC), metastatic gastroesophageal cancer ...